Walk this Way: a pilot study investigating the effect of a motivational pedometer based walking intervention to reduce sedentary behaviour and increase activity levels of people with serious mental illness
Not Applicable
Completed
- Conditions
- Serious mental illness defined as schizophrenia, bipolar disorder or major depressionMental and Behavioural Disorders
- Registration Number
- ISRCTN37724980
- Lead Sponsor
- King's College London
- Brief Summary
2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31533686 results (added 20/09/2019) 2016 Protocol article in https://pubmed.ncbi.nlm.nih.gov/27955680/ (added 10/10/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1. Has a serious mental illness
2. Is any of: overweight, diabetic, smokes tobacco, has a sedentary lifestyle
3. Uses secondary mental health services
Exclusion Criteria
1. Has no physical health issue as listed in inclusion criteria
3. Is unable to give informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amount of sedentary behaviour and physical activity measured by an accelerometer which will be worn by participants for 4 days before and after the intervention
- Secondary Outcome Measures
Name Time Method <br> 1. BMI and waist circumference<br> 2. Self report sedentary behaviour and physical activity measured using the International Physical Activity Questionnaire<br> 3. Motivation to engage in physical activity measured using the Behavioural Regulation in Exercise Questionnaire 2<br> 4. insulin resistance, long-term blood glucose control, fasting lipids and c reactive protein measured from blood samples collected from participants<br> 5. Mental well-being measured using the Warwick Edinburgh Mental Well-being Scale<br> 6. Functional mobility measured using the Timed Get up and Go (TUG) Test<br> All outcomes, primary and secondary, will be measured at baseline and follow-up, which is at the end of the 16-week intervention.<br>